Navigation Links
Cleveland LASIK and Cataract Surgeon Dr Michael Rom Speaks in Israel
Date:5/2/2013

Cleveland, OH (PRWEB) May 02, 2013

A very unique opportunity was presented this year to Cleveland ophthalmologist, Michael Rom, M.D. In January, Dr. Rom was invited to speak to almost 250 fellow ophthalmologists at the 2013 Ophthalmic Microsurgical conference in Israel.

“Being able to connect with my colleagues in another country, to be that connection to new technology in a way that they had not experienced before, that was really special,” says Dr. Rom.

Dr. Rom delivered his lectures in English, but was able to answer questions in Hebrew, allowing for him to share specific business tips and experiences in a way that his colleagues could grasp and understand. The main subject of Dr. Rom’s lectures was ORA (Optiwave Refractive Analysis). ORA is an intraoperative aberrometer that allows Dr. Rom to provide Cleveland cataract patients with real-time measurements during cataract surgery. This was a unique opportunity not only to talk to foreign colleagues, but to speak on a topic in which they had no experience because in a rare instance, the FDA has approved the technology before Europe.

“The people of Israel are very technologically advanced, but have not had experience with something like ORA,” says Dr. Rom. “This was exciting to be able to show them such a simple procedure, but with so much upside. I feel like this is the next leap in what we can offer patients. Everyone hopes and dreams that they can give premium care and make patients happy, and this gives us peace of mind that we are offering premium care.”

Dr. Rom says he hopes that he was able to make an impact by sharing his knowledge and hopefully growing the profession. “It’s about the quest for knowledge and practical knowledge. You can show people stats and graphs, but still a lot of professionals want to hear about the practicality and the clinical implications for the patient. I feel a sense of accomplishment, I was able to go to another country, speak with people I’ve never met, and connect on a professional level.”

About Dr. Rom:
Dr. Michael Rom is a Board-Certified ophthalmologist who specializes in cataract and LASIK surgery. He completed his ophthalmology residency at the Cleveland Clinic Foundation.
In his 18 years of ophthalmic experience, Dr. Rom has performed over 19,000 cataracts/glaucoma procedures, and 18,000 LASIK procedures. His ophthalmology practice has flourished because he is so well liked by his patients and because his reputation for great patient care and service. Their comfort and care are his top priority.

Insight Eye Center:

Mentor
(440) 205-5840
9485 Mentor Ave., Suite 200
Mentor, OH 44060

Chardon
(440) 286-1188
13170 Ravenna Rd, Suite 204
Chardon, OH 44024

http://www.insighteyecenter.com
https://www.facebook.com/pages/Insight-Eye-Center-Office-of-Michael-E-Rom-MD/268243653202000

Read the full story at http://www.prweb.com/releases/2013/5/prweb10691690.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Cleveland Clinic selected to participate in National MDS Clinical Research Consortium
2. Cleveland Clinic researchers discover molecule that may prevent atherosclerosis
3. Cleveland Clinic Florida receives approval for transplant programs at Weston Facilities
4. Cleveland Clinic researchers investigating potential drug for treatment of Alzheimers disease
5. Cleveland Clinic study shows vitamin E may decrease cancer risk in Cowden syndrome patients
6. University Hospitals & Philips Healthcare to showcase imaging technology at Cleveland Medical Mart
7. Cleveland Clinic researcher identifies 2 new genetic mutations associated with Cowden syndrome
8. Redskins Quarterback & Lynx Shreds Athlete Kirk Cousins will Start Today vs. Cleveland Browns for Injured RG3
9. Cleveland Clinic researcher receives grant to fund autism research
10. Cleveland Clinic study shows bariatric surgery restores pancreatic function by targeting belly fat
11. Vein Expert in Winston-Salem, NC Participates in Elite Cleveland Clinic Seminar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology: